(ASML) ASML Holding - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0010273215
Stock: Lithography, Metrology, Inspection, Software, Services
Total Rating 80
Risk 97
Buy Signal 1.08
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 1.47% |
| Yield CAGR 5y | 18.29% |
| Payout Consistency | 85.1% |
| Payout Ratio | 26.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.9% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.46 |
| Alpha | 56.52 |
| Character TTM | |
|---|---|
| Beta | 0.486 |
| Beta Downside | 0.488 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.77% |
| CAGR/Max DD | 0.65 |
Description: ASML ASML Holding February 05, 2026
ASML Holding N.V. designs, manufactures, and services advanced lithography equipment used to pattern integrated circuits, including extreme-ultraviolet (EUV) and deep-ultraviolet (DUV) systems, as well as metrology, inspection, and computational lithography solutions. Its product portfolio enables chipmakers to produce nodes from 7 nm down to sub-2 nm, and the company also offers system upgrades, refurbishment, and ongoing customer support across a global footprint that spans Europe, Asia, the Middle East, Africa, and the United States.
As of FY 2023, ASML reported €21.2 billion in revenue and an order intake of €31 billion, reflecting a backlog that now exceeds $40 billion-an indicator of sustained demand for its EUV tools. The firm commands roughly 70 % of the worldwide EUV market share, a position reinforced by the accelerating rollout of AI-centric data-center chips and the broader shift toward advanced-node semiconductor manufacturing. R&D intensity remains high, with spending at about 15 % of revenue, underscoring the capital-intensive nature of maintaining technological leadership.
For a deeper quantitative dive, see the ASML profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 9.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 3.24 > 1.0 |
| NWC/Revenue: 19.45% < 20% (prev 37.81%; Δ -18.36% < -1%) |
| CFO/TA 0.26 > 3% & CFO 13.26b > Net Income 9.61b |
| Net Debt (-10.21b) to EBITDA (12.41b): -0.82 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (387.0m) vs 12m ago -1.68% < -2% |
| Gross Margin: 52.83% > 18% (prev 0.51%; Δ 5232 % > 0.5%) |
| Asset Turnover: 65.89% > 50% (prev 58.17%; Δ 7.72% > 0%) |
| Interest Coverage Ratio: -48.23 > 6 (EBITDA TTM 12.41b / Interest Expense TTM -236.1m) |
Beneish M -3.26
| DSRI: 0.66 (Receivables 4.17b/5.44b, Revenue 32.67b/28.26b) |
| GMI: 0.97 (GM 52.83% / 51.28%) |
| AQI: 1.06 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.16 (Revenue 32.67b / 28.26b) |
| TATA: -0.07 (NI 9.61b - CFO 13.26b) / TA 50.57b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of ASML shares?
As of February 07, 2026, the stock is trading at EUR 1193.80 with a total of 545,398 shares traded.
Over the past week, the price has changed by -1.79%, over one month by +12.52%, over three months by +33.34% and over the past year by +68.52%.
Over the past week, the price has changed by -1.79%, over one month by +12.52%, over three months by +33.34% and over the past year by +68.52%.
Is ASML a buy, sell or hold?
ASML Holding has no consensus analysts rating.
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1367.6 | 14.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1508.8 | 26.4% |
ASML Fundamental Data Overview February 07, 2026
Market Cap USD = 526.58b (446.21b EUR * 1.1801 EUR.USD)
P/E Trailing = 46.4485
P/E Forward = 40.3226
P/S = 13.6594
P/B = 22.5738
P/EG = 2.2793
Revenue TTM = 32.67b EUR
EBIT TTM = 11.39b EUR
EBITDA TTM = 12.41b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.21b EUR (from netDebt column, last quarter)
Enterprise Value = 435.60b EUR (446.21b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = -48.23 (Ebit TTM 11.39b / Interest Expense TTM -236.1m)
EV/FCF = 39.28x (Enterprise Value 435.60b / FCF TTM 11.09b)
FCF Yield = 2.55% (FCF TTM 11.09b / Enterprise Value 435.60b)
FCF Margin = 33.94% (FCF TTM 11.09b / Revenue TTM 32.67b)
Net Margin = 29.42% (Net Income TTM 9.61b / Revenue TTM 32.67b)
Gross Margin = 52.83% ((Revenue TTM 32.67b - Cost of Revenue TTM 15.41b) / Revenue TTM)
Gross Margin QoQ = 52.16% (prev 51.63%)
Tobins Q-Ratio = 8.61 (Enterprise Value 435.60b / Total Assets 50.57b)
Interest Expense / Debt = 0.03% (Interest Expense 800.0k / Debt 2.71b)
Taxrate = 17.89% (618.7m / 3.46b)
NOPAT = 9.35b (EBIT 11.39b * (1 - 17.89%))
Current Ratio = 1.26 (Total Current Assets 30.62b / Total Current Liabilities 24.26b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.61b)
Debt / EBITDA = -0.82 (Net Debt -10.21b / EBITDA 12.41b)
Debt / FCF = -0.92 (Net Debt -10.21b / FCF TTM 11.09b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.38% (Net Income 9.61b / Total Assets 50.57b)
RoE = 52.14% (Net Income TTM 9.61b / Total Stockholder Equity 18.43b)
RoCE = 53.86% (EBIT 11.39b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 292.3% (NOPAT 9.35b / Invested Capital 3.20b)
WACC = 7.65% (E(446.21b)/V(448.92b) * Re(7.70%) + D(2.71b)/V(448.92b) * Rd(0.03%) * (1-Tc(0.18)))
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.87%
[DCF Debug] Terminal Value 75.22% ; FCFF base≈10.29b ; Y1≈7.97b ; Y5≈5.06b
Fair Price DCF = 285.8 (EV 100.72b - Net Debt -10.21b = Equity 110.93b / Shares 388.1m; r=7.65% [WACC]; 5y FCF grow -26.82% → 2.90% )
EPS Correlation: 63.88 | EPS CAGR: 47.02% | SUE: -1.18 | # QB: 0
Revenue Correlation: 76.84 | Revenue CAGR: 30.96% | SUE: 0.94 | # QB: 1
EPS next Quarter (2026-03-31): EPS=6.65 | Chg30d=+1.114 | Revisions Net=+6 | Analysts=14
EPS current Year (2026-12-31): EPS=29.33 | Chg30d=+3.164 | Revisions Net=+24 | Growth EPS=+18.7% | Growth Revenue=+13.2%
EPS next Year (2027-12-31): EPS=36.71 | Chg30d=+4.478 | Revisions Net=+23 | Growth EPS=+25.2% | Growth Revenue=+17.2%
P/E Trailing = 46.4485
P/E Forward = 40.3226
P/S = 13.6594
P/B = 22.5738
P/EG = 2.2793
Revenue TTM = 32.67b EUR
EBIT TTM = 11.39b EUR
EBITDA TTM = 12.41b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.21b EUR (from netDebt column, last quarter)
Enterprise Value = 435.60b EUR (446.21b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = -48.23 (Ebit TTM 11.39b / Interest Expense TTM -236.1m)
EV/FCF = 39.28x (Enterprise Value 435.60b / FCF TTM 11.09b)
FCF Yield = 2.55% (FCF TTM 11.09b / Enterprise Value 435.60b)
FCF Margin = 33.94% (FCF TTM 11.09b / Revenue TTM 32.67b)
Net Margin = 29.42% (Net Income TTM 9.61b / Revenue TTM 32.67b)
Gross Margin = 52.83% ((Revenue TTM 32.67b - Cost of Revenue TTM 15.41b) / Revenue TTM)
Gross Margin QoQ = 52.16% (prev 51.63%)
Tobins Q-Ratio = 8.61 (Enterprise Value 435.60b / Total Assets 50.57b)
Interest Expense / Debt = 0.03% (Interest Expense 800.0k / Debt 2.71b)
Taxrate = 17.89% (618.7m / 3.46b)
NOPAT = 9.35b (EBIT 11.39b * (1 - 17.89%))
Current Ratio = 1.26 (Total Current Assets 30.62b / Total Current Liabilities 24.26b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.61b)
Debt / EBITDA = -0.82 (Net Debt -10.21b / EBITDA 12.41b)
Debt / FCF = -0.92 (Net Debt -10.21b / FCF TTM 11.09b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.38% (Net Income 9.61b / Total Assets 50.57b)
RoE = 52.14% (Net Income TTM 9.61b / Total Stockholder Equity 18.43b)
RoCE = 53.86% (EBIT 11.39b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 292.3% (NOPAT 9.35b / Invested Capital 3.20b)
WACC = 7.65% (E(446.21b)/V(448.92b) * Re(7.70%) + D(2.71b)/V(448.92b) * Rd(0.03%) * (1-Tc(0.18)))
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.87%
[DCF Debug] Terminal Value 75.22% ; FCFF base≈10.29b ; Y1≈7.97b ; Y5≈5.06b
Fair Price DCF = 285.8 (EV 100.72b - Net Debt -10.21b = Equity 110.93b / Shares 388.1m; r=7.65% [WACC]; 5y FCF grow -26.82% → 2.90% )
EPS Correlation: 63.88 | EPS CAGR: 47.02% | SUE: -1.18 | # QB: 0
Revenue Correlation: 76.84 | Revenue CAGR: 30.96% | SUE: 0.94 | # QB: 1
EPS next Quarter (2026-03-31): EPS=6.65 | Chg30d=+1.114 | Revisions Net=+6 | Analysts=14
EPS current Year (2026-12-31): EPS=29.33 | Chg30d=+3.164 | Revisions Net=+24 | Growth EPS=+18.7% | Growth Revenue=+13.2%
EPS next Year (2027-12-31): EPS=36.71 | Chg30d=+4.478 | Revisions Net=+23 | Growth EPS=+25.2% | Growth Revenue=+17.2%